Transcription profiling of human tamoxifen treated myeloid leukemia K562-MERT cells

ABSTRACT: K562 cells, a myeloid leukemia cells line, were engineered to express a tamoxifen inducible dominant negative Myb (MERT). K562-MERT cells were cultured for 3 days in the absence and presence of 1 uM tamoxifen. The RNA was then extracted from the untreated and tamoxifen treated K562-MERT cells and submitted to Incyte Genomics for poly(A) RNA selection, probe preparation, hybridization of the labeled cDNA to the micorarray chip (Incyte Genomics) and data analysis.

ORGANISM(S): Homo sapiens

DISEASE(S): chronic myelogenous leukemia

SUBMITTER: Susan Shetzline 

PROVIDER: E-MEXP-91 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress